| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |